{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:36:46Z","timestamp":1792255006386,"version":"4.4.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.arbres.2026.04.001","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:08:29Z","timestamp":1775840909000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): An Official 2025 ALAT Clinical Practice Guideline"],"prefix":"10.1016","author":[{"given":"Mar\u00eda Laura","family":"Alberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago Jos\u00e9","family":"Auteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Rojas-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Citera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivette","family":"Buend\u00eda-Roldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Babini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Vinicio","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cachafeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Enghelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas","family":"Florenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Garc\u00eda-Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente Gir\u00f3n","family":"Atoche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licia Mar\u00eda Henrique","family":"da Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo Adib","family":"Kairalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn Acu\u00f1a","family":"Izcaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efra\u00edn","family":"Sanchez-Angarita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Machado","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra","family":"Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin Mueller","family":"Storrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Noboa-Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Noriega-Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rinc\u00f3n-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Tavera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Enrique Toro","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Dieud\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabi\u00e1n Mat\u00edas","family":"Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.arbres.2026.04.001_bib0470","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid arthritis \u2013 common origins, divergent mechanisms","volume":"388","author":"Gravallese","year":"2023","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.arbres.2026.04.001_bib0475","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0480","article-title":"The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"56","author":"Wang","year":"2024","journal-title":"Ann Med"},{"issue":"2","key":"10.1016\/j.arbres.2026.04.001_bib0485","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.arbres.2026.04.001_bib0490","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1093\/rheumatology\/keab891","article-title":"Screening for preclinical parenchymal lung disease in rheumatoid arthritis","volume":"61","author":"Esposito","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"SI3","key":"10.1016\/j.arbres.2026.04.001_bib0495","doi-asserted-by":"crossref","first-page":"SI286","DOI":"10.1093\/rheumatology\/kead277","article-title":"Prevalence and mortality associations of interstitial lung abnormalities in rheumatoid arthritis within a multicentre prospective cohort of smokers","volume":"62","author":"McDermott","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"38","key":"10.1016\/j.arbres.2026.04.001_bib0500","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017088","article-title":"High-resolution computed tomography of the lung in patients with rheumatoid arthritis: prevalence of interstitial lung disease involvement and determinants of abnormalities","volume":"98","author":"Salaffi","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.arbres.2026.04.001_bib0505","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.arbres.2026.04.001_bib0510","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arbres.2026.04.001_bib0515","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","article-title":"A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality","volume":"76","author":"Hyldgaard","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arbres.2026.04.001_bib0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107282","article-title":"Rheumatoid arthritis associated interstitial lung disease: Trends in epidemiology and mortality in Ontario from 2000 to 2018","author":"Fidler","year":"2023","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0525","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12931-021-01856-z","article-title":"Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"22","author":"Qiu","year":"2021","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.arbres.2026.04.001_bib0530","first-page":"323","article-title":"Serum biomarkers of pulmonary damage and risk for progression of rheumatoid arthritis-associated interstitial lung disease","volume":"52","author":"Chang","year":"2025","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0535","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.1038\/s41598-021-88734-2","article-title":"Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis","volume":"11","author":"Cano-Jim\u00e9nez","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.arbres.2026.04.001_bib0540","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s10067-021-06040-8","article-title":"Rheumatoid arthritis-related interstitial lung disease (RA-ILD): a possible association between disease activity and prognosis","volume":"41","author":"Rojas-Serrano","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.arbres.2026.04.001_bib0545","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.40904","article-title":"Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study","volume":"71","author":"Sparks","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.arbres.2026.04.001_bib0550","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1093\/rheumatology\/keac208","article-title":"The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease","volume":"61","author":"Brooks","year":"2022","journal-title":"Rheumatol (Oxf)"},{"issue":"4","key":"10.1016\/j.arbres.2026.04.001_bib0555","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/rheumatology\/kead317","article-title":"Impact of interstitial lung disease on clinical remission and unfavourable events of rheumatoid arthritis: results from the IORRA cohort","volume":"63","author":"Sugano","year":"2024","journal-title":"Rheumatol (Oxf)"},{"issue":"2","key":"10.1016\/j.arbres.2026.04.001_bib0560","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.reuma.2021.12.006","article-title":"Screening criteria for interstitial lung disease associated to rheumatoid arthritis: expert proposal based on Delphi methodology","volume":"19","author":"Narv\u00e1ez","year":"2023","journal-title":"Reumatol Clin"},{"issue":"8","key":"10.1016\/j.arbres.2026.04.001_bib0565","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.reuma.2022.02.009","article-title":"SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis","volume":"18","author":"Rodr\u00edguez Portal","year":"2022","journal-title":"Reumatol Clin"},{"issue":"9","key":"10.1016\/j.arbres.2026.04.001_bib0570","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.reuma.2022.03.005","article-title":"SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment","volume":"18","author":"Narv\u00e1ez","year":"2022","journal-title":"Reumatol Clin"},{"issue":"8","key":"10.1016\/j.arbres.2026.04.001_bib0575","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.42861","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.arbres.2026.04.001_bib0580","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0585","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00952-2017","article-title":"Taken to task: what is and is not an appropriate response to an ERS guidelines task force?","volume":"50","author":"Joos","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.arbres.2026.04.001_bib0590","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1016\/S2665-9913(24)00265-0","article-title":"Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort study","volume":"7","author":"England","year":"2025","journal-title":"Lancet Rheumatol"},{"issue":"7","key":"10.1016\/j.arbres.2026.04.001_bib0595","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1164\/rccm.202505-1054ST","article-title":"Approach to the evaluation and management of interstitial lung abnormalities: an official american thoracic society clinical statement","volume":"211","author":"Podolanczuk","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"10.1016\/j.arbres.2026.04.001_bib0600","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa2503643","article-title":"Nerandomilast in patients with progressive pulmonary fibrosis","volume":"392","author":"Maher","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2026.04.001_bib0605","series-title":"Evidence-based medicine workbook","author":"Glasziou","year":"2003"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0610","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1038\/s41598-025-88323-7","article-title":"Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study","volume":"15","author":"Kim","year":"2025","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.arbres.2026.04.001_bib0615","doi-asserted-by":"crossref","first-page":"e003491","DOI":"10.1136\/rmdopen-2023-003491","article-title":"Increased mortality in patients with RA-associated interstitial lung disease: data from a French administrative healthcare database","volume":"9","author":"Juge","year":"2023","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.arbres.2026.04.001_bib0620","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/BOR.0000000000000703","article-title":"Management issues in rheumatoid arthritis-associated interstitial lung disease","volume":"32","author":"England","year":"2020","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.arbres.2026.04.001_bib0625","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/acr.25432","article-title":"Impact of sex, serostatus, and smoking on risk for rheumatoid arthritis-associated interstitial lung disease subtypes","volume":"77","author":"McDermott","year":"2025","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.arbres.2026.04.001_bib0630","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","article-title":"Pulmonary involvement in rheumatoid arthritis","volume":"25","author":"Bilgici","year":"2005","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.arbres.2026.04.001_bib0635","first-page":"1513","article-title":"Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis","volume":"35","author":"Mori","year":"2008","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.arbres.2026.04.001_bib0640","first-page":"S316","article-title":"Ultrasound evaluation of interstitial lung disease in rheumatoid arthritis and autoimmune diseases","volume":"11","author":"Esther","year":"2024","journal-title":"Eur J Rheumatol"},{"issue":"8","key":"10.1016\/j.arbres.2026.04.001_bib0645","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3899\/jrheum.120104","article-title":"Ultrasound in the assessment of pulmonary fibrosis in connective tissue disorders: correlation with high-resolution computed tomography","volume":"39","author":"Tardella","year":"2012","journal-title":"J Rheumatol"},{"issue":"17","key":"10.1016\/j.arbres.2026.04.001_bib0650","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.3390\/diagnostics14171890","article-title":"A systematic review of the key predictors of progression and mortality of rheumatoid arthritis-associated interstitial lung disease","volume":"14","author":"Groseanu","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"10","key":"10.1016\/j.arbres.2026.04.001_bib0655","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.reuma.2021.07.008","article-title":"Screening of interstitial lung disease in patients with rheumatoid arthritis: a systematic review","volume":"18","author":"Garrote-Corral","year":"2022","journal-title":"Reumatol Clin"},{"issue":"11","key":"10.1016\/j.arbres.2026.04.001_bib0660","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.42162","article-title":"A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease","volume":"74","author":"Juge","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0665","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12890-019-0875-x","article-title":"Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device)","volume":"19","author":"Manfredi","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.arbres.2026.04.001_bib0670","article-title":"Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis","volume":"10","author":"Guiot","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.arbres.2026.04.001_bib0675","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/acr.25351","article-title":"Detection of interstitial lung disease in rheumatoid arthritis by thoracic ultrasound: a diagnostic test accuracy study","volume":"76","author":"Sof\u00edud\u00f3ttir","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.arbres.2026.04.001_bib0680","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/OARRR.S441720","article-title":"Usefulness of lung ultrasound as a method for early diagnosis of interstitial lung disease in patients with rheumatoid arthritis","volume":"16","author":"Santos-Moreno","year":"2024","journal-title":"Open Access Rheumatol"},{"issue":"7","key":"10.1016\/j.arbres.2026.04.001_bib0685","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/resp.14679","article-title":"Lung ultrasound is a promising screening tool to rule out interstitial lung disease in patients with rheumatoid arthritis","volume":"29","author":"Otaola","year":"2024","journal-title":"Respirology"},{"issue":"8","key":"10.1016\/j.arbres.2026.04.001_bib0690","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00296-023-05313-6","article-title":"Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis","volume":"43","author":"Koduri","year":"2023","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.arbres.2026.04.001_bib0695","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.reuma.2019.05.007","article-title":"Development of a risk indicator score for the identification of interstitial lung disease in patients with rheumatoid arthritis","volume":"17","author":"Paulin","year":"2021","journal-title":"Reumatol Clin"},{"issue":"9","key":"10.1016\/j.arbres.2026.04.001_bib0700","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-015-3025-8","article-title":"Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis","volume":"34","author":"Restrepo","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0705","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13075-024-03333-6","article-title":"Rheumatoid arthritis disease activity significantly impacts on the severity of interstitial lung disease","volume":"26","author":"Ito","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.arbres.2026.04.001_bib0710","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1269","article-title":"Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials","volume":"350","author":"Conway","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0715","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10067-011-1758-6","article-title":"How common is methotrexate pneumonitis? A large prospective study investigates","volume":"31","author":"Sathi","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.arbres.2026.04.001_bib0720","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/acr.24596","article-title":"2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.arbres.2026.04.001_bib0725","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/03009740601153774","article-title":"Rheumatoid arthritis treatment and the risk of severe interstitial lung disease","volume":"36","author":"Wolfe","year":"2007","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0730","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/rheumatology\/keaa327","article-title":"Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study","volume":"60","author":"Ibfelt","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.arbres.2026.04.001_bib0735","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.reuma.2020.04.015","article-title":"Systematic review of the impact of drugs on diffuse interstitial lung disease associated with rheumatoid arthritis","volume":"17","author":"Carrasco Cubero","year":"2021","journal-title":"Reumatol Clin"},{"issue":"2","key":"10.1016\/j.arbres.2026.04.001_bib0740","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00337-2020","article-title":"Methotrexate and rheumatoid arthritis associated interstitial lung disease","volume":"57","author":"Juge","year":"2021","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.arbres.2026.04.001_bib0745","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.arbres.2026.04.001_bib0750","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/rheumatology\/keac651","article-title":"Methotrexate, leflunomide and tacrolimus use and the progression of rheumatoid arthritis-associated interstitial lung disease","volume":"62","author":"Kim","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.arbres.2026.04.001_bib0755","doi-asserted-by":"crossref","first-page":"e005615","DOI":"10.1136\/bmjopen-2014-005615","article-title":"Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis","volume":"4","author":"Nakashita","year":"2014","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.arbres.2026.04.001_bib0760","doi-asserted-by":"crossref","first-page":"317","DOI":"10.46497\/ArchRheumatol.2024.10199","article-title":"Rituximab for rheumatoid arthritis-related interstitial lung disease: a systematic review and meta-analysis","volume":"39","author":"Krishna Boppana","year":"2024","journal-title":"Arch Rheumatol"},{"issue":"2","key":"10.1016\/j.arbres.2026.04.001_bib0765","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/1756-185X.14495","article-title":"Rituximab for connective tissue disease-associated interstitial lung disease: a systematic review and meta-analysis","volume":"26","author":"Wang","year":"2023","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"10.1016\/j.arbres.2026.04.001_bib0770","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.chest.2022.11.035","article-title":"Treatment outcomes for rheumatoid arthritis-associated interstitial lung disease: a real-world, multisite study of the impact of immunosuppression on pulmonary function trajectory","volume":"163","author":"Matson","year":"2023","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.arbres.2026.04.001_bib0775","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/rheumatology\/kez673","article-title":"Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry","volume":"59","author":"Vadillo","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.arbres.2026.04.001_bib0780","article-title":"Abatacept for rheumatoid arthritis","volume":"2009","author":"Maxwell","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.arbres.2026.04.001_bib0785","first-page":"1882","article-title":"Analysis of efficacy and safety of abatacept for rheumatoid arthritis: systematic review and meta-analysis","volume":"41","author":"Mohamed Ahamada","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.arbres.2026.04.001_bib0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102830","article-title":"Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: a systematic literature review","volume":"20","author":"Vicente-Rabaneda","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.arbres.2026.04.001_bib0795","doi-asserted-by":"crossref","first-page":"e003487","DOI":"10.1136\/rmdopen-2023-003487","article-title":"Efficacy of non-conventional synthetic DMARDs for patients with rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"9","author":"Yuan","year":"2023","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.arbres.2026.04.001_bib0800","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3390\/biomedicines10071480","article-title":"Safety and effectiveness of abatacept in a prospective cohort of patients with rheumatoid arthritis-associated interstitial lung disease","volume":"10","author":"Mena-V\u00e1zquez","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0805","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/rheumatology\/keab317","article-title":"Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis-multicentre study of 263 Caucasian patients","volume":"61","author":"Fern\u00e1ndez-D\u00edaz","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arbres.2026.04.001_bib0810","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejim.2023.08.025","article-title":"Abatacept in usual and in non-specific interstitial pneumonia associated with rheumatoid arthritis","volume":"119","author":"Atienza-Mateo","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.arbres.2026.04.001_bib0815","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.resinv.2023.02.007","article-title":"Radiological evaluation of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept or JAK inhibitors for 1 year","volume":"61","author":"Mochizuki","year":"2023","journal-title":"Respir Investig"},{"key":"10.1016\/j.arbres.2026.04.001_bib0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152517","article-title":"Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients","volume":"68","author":"L\u00f3pez-Maraver","year":"2024","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0825","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41927-024-00374-x","article-title":"Janus kinase inhibitors vs. abatacept about safety and efficacy for patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective nested case\u2013control study","volume":"8","author":"Tsujii","year":"2024","journal-title":"BMC Rheumatol"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0830","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s10238-024-01448-3","article-title":"Abatacept versus tumor necrosis factor inhibitors on mortality and medical utilizations in the treatment of rheumatoid arthritis associated interstitial lung disease: a large-scale real-world retrospective cohort study","volume":"24","author":"Shih","year":"2024","journal-title":"Clin Exp Med"},{"issue":"2","key":"10.1016\/j.arbres.2026.04.001_bib0835","first-page":"247","article-title":"Retention rate and safety of biologic and targeted synthetic DMARDs in patients with RA-associated interstitial lung disease: a KOBIO registry study","volume":"37","author":"Lee","year":"2023","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0840","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/biom13010119","article-title":"The role of JAK\/STAT pathway in fibrotic diseases: molecular and cellular mechanisms","volume":"13","author":"Liu","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.arbres.2026.04.001_bib0845","article-title":"A prospective observational cohort study of the efficacy of tofacitinib plus iguratimod on rheumatoid arthritis with usual interstitial pneumonia","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.arbres.2026.04.001_bib0850","first-page":"2071","article-title":"Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data","volume":"40","author":"Kalyoncu","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.arbres.2026.04.001_bib0855","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/jcm12030957","article-title":"Evolution of rheumatoid-arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a retrospective exploratory study","volume":"12","author":"Venerito","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.arbres.2026.04.001_bib0860","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.arbres.2026.04.001_bib0865","first-page":"2318","article-title":"Antifibrotic agents in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"13","author":"Jang","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.arbres.2026.04.001_bib0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107329","article-title":"Efficacy and safety of antifibrotic agents in the treatment of CTD-ILD and RA-ILD: a systematic review and meta-analysis","volume":"216","author":"Yang","year":"2023","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2026.04.001_bib0875","article-title":"The efficacy and safety of pirfenidone combined with immunosuppressant therapy in connective tissue disease-associated interstitial lung disease: a 24-week prospective controlled cohort study","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.arbres.2026.04.001_bib0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152312","article-title":"Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease","volume":"64","author":"Juge","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.arbres.2026.04.001_bib0885","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0890","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.reuma.2014.02.007","article-title":"Rheumatoid arthritis-associated interstitial lung disease: lung inflammation evaluated with high resolution computed tomography scan is correlated to rheumatoid arthritis disease activity","volume":"11","author":"P\u00e9rez-D\u00f3rame","year":"2015","journal-title":"Reumatol Clin"},{"issue":"8","key":"10.1016\/j.arbres.2026.04.001_bib0895","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.rmed.2013.05.002","article-title":"Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD)","volume":"107","author":"Solomon","year":"2013","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0900","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00869-2018","article-title":"Predicting outcomes in rheumatoid arthritis related interstitial lung disease","volume":"53","author":"Jacob","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.arbres.2026.04.001_bib0905","article-title":"Cyclophosphamide for treating rheumatoid arthritis","author":"Suarez-Almazor","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.arbres.2026.04.001_bib0910","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/art.41752","article-title":"2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.001_bib0915","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"22","key":"10.1016\/j.arbres.2026.04.001_bib0920","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.3390\/jcm12227041","article-title":"Fibrosing progressive interstitial lung disease in rheumatoid arthritis: a multicentre Italian study","volume":"12","author":"Sebastiani","year":"2023","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.arbres.2026.04.001_bib0925","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.04.001_bib0930","article-title":"Progression of radiographic fibrosis in rheumatoid arthritis-associated interstitial lung disease","volume":"10","author":"Chai","year":"2023","journal-title":"Front Med (Lausanne)"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289626001225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289626001225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T19:49:14Z","timestamp":1777060154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289626001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":93,"alternative-id":["S0300289626001225"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2026.04.001","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): An Official 2025 ALAT Clinical Practice Guideline","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2026.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}